Treatment of intravenous thrombolysis with half dose recombinant human prourokinase reducing the rate of tirofiban use during early routine catheterization period.
Asian journal of surgery（2022）
Key words
Catheterization,No-reflow,Percutaneous coronary intervention,Recombinant human prourokinase,Slow flow,Tirofiban
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined